![]() |
|
|

* Department of Neuroscience, University of Florida McKnight Brain Institute, Gainesville, FL 32610-0244;
Division of Diabetes, Digestive & Kidney Disease, Department of Clinical Molecular Medicine, Kobe University Graduate School of Medicine, 75-1 Kusunoki, Cho, Chuo-Ky, Kobe, Japan; and
** Department of Physiology & Functional Genomics, University of Florida, Gainesville, FL 32610-0274
3To whom correspondence should be addressed. E-mail: skalra{at}mbi.ufl.edu.
| ABSTRACT |
|---|
|
|
|---|
KEY WORDS: ghrelin leptin rhythms restraint obesity
Daily meal patterning is a highly regulated phenomenon. In vertebrates, the intermittent feeding pattern is integrated in the hypothalamus wherein the effector pathways transduce information from metabolic, neural, and hormonal signals and the circadian clock to initiate and terminate a meal (1,2). An interconnected appetite-regulating network (ARN)4 (3) of neuropeptide Y (NPY) and cohorts in the hypothalamic arcuate nucleus-paraventricular nucleus (ARC-PVN) axis is apparently the primary neuroanatomical substrate for elaborating and emitting orexigenic and anorexigenic signals in circadian and ultradian rhythmic patterns (14). Various studies show that reciprocal rhythmicities in 2 peripheral hormones, anorexigenic leptin from adipocytes and orexigenic ghrelin from the stomach, are the major afferent signals for the timely activation of the ARN (2,46) (Fig. 1). Our concerted efforts to delineate feedback communication between the periphery and ARN for maintenance of energy homeostasis on a daily basis has provided new insights at several fronts. These include: 1) existence of a temporal causal relation between rhythmic NPY secretion in the ARC-PVN axis and rhythmic afferent hormonal feedback signals (2,58), 2) evidence that derangement in onset, periodicity, duration, or magnitude of afferent feedback signaling imposes a corresponding abnormality in periodic NPY discharge that precedes excessive energy intake and fat accretion (3,4,8), 3) identification of leptin as the primary signal that concurrently augments nonshivering thermogenesis and restrains the orexigenic effects of ghrelin at central and peripheral targets (913).
|
Ghrelin: a peripheral and central orexigen
Among a spectrum of peripheral afferent hormonal signals examined so far, ghrelin is currently the only known hormone to readily stimulate feeding and promote adiposity after peripheral administration (1,2,14,15). In addition, the ghrelin produced by neurons in the subparaventricular zone of the hypothalamus is also believed to be orexigenic within the ARN (16). Several lines of evidence suggest that ghrelin may serve as one of the physiologically relevant signals in stimula-tion of episodic feeding. A premeal rise in circulating ghrelin levels (1720), attenuated feeding following pharmacologic suppression of action of this antecedent rise (21), and decline in ghrelin secretion postprandially (22) are in accord with this notion. Perhaps the strongest evidence is provided by the dynamic secretion patterns of ghrelin in accordance with fluctuations in energy reserves. Ghrelin is normally secreted in an episodic fashion (5) (Fig. 2). In sated rats, ghrelin secretory episodes consist of low-amplitude pulses discharged at a regular frequency of about 2 episodes/h. However, robust appetitive drive elicited by the negative energy balance after food deprivation coincides with high-amplitude pulses at accelerated frequency of about 3 episodes/h. Thus, when energy intake and expenditure are balanced, ghrelin secretion is restrained but reduced energy resources rapidly curb this restraint to allow increased episodic ghrelin discharge (5). What are the neural and hormonal signals that propagate rhythmic ghrelin secretion preceding feeding and accelerated rhythms in response to energy insufficiency? Does leptin, an anorexigen, modulate ghrelin secretion?
|
Rhythmic fluctuations in circulating levels of leptin in sated rats and in response to shifts in energy balance experimentally have also been observed (5,6). Leptin is secreted in a pulsatile manner with a frequency of discharge similar to that of ghrelin (5,6) (Fig. 3). However, in marked contrast to the acceleration in ghrelin secretion, energy deprivation diminishes leptin pulse amplitude, thereby diminishing overall leptin output (5) (Fig. 3). A reciprocal relation between circulating ghrelin and leptin is also seen normally on a daily basis in rats. Premeal ghrelin hypersecretion at the onset of dark-phase ingestive behavior and preceding the time of food availability in a scheduled feeding paradigm is coincident with low circulating levels of leptin (19,23). On the other hand, a gradual rise in leptin hypersecretion precedes the postprandial decline in ghrelin secretion (19,22,23).
|
There is also an opposing relation, ghrelin hypersecretion in conjunction with leptinopenia in another experimental model. A nonpathogenic and replicative deficient vector, recombinant adeno-associated virus encoding the leptin gene (rAAV-lep), injected either intracerebroventricularly or microinjected into discrete hypothalamic sites of normal or diet-induced obese rats and mice, suppressed weight gain and adiposity and markedly suppressed circulating leptin levels for over 1 y duration of the experiments (11,13,2529). Quite unexpectedly, we uniformly observed ghrelin hypersecretion accompanying the prolonged and severe leptinopenia and loss of adiposity in these rats and mice. Remarkably, despite markedly increased circulating ghrelin level in these rAAV-lep-treated rats and mice, food intake was suppressed. Evidently, a central restraint on the appetite-stimulating effects of ghrelin in these leptin transgeneexpressing rats and mice was in effect.
Leptinopenia concomitant with increased episodic ghrelin secretion in food-deprived and rAAV-lep treated mice on the one hand and hyperleptinemia associated with diminished intermittent ghrelin output in obese mice on the other, together with the reciprocal relation between these 2 hormones pre- and postprandially, led us to postulate that leptin may exert a tonic restraint on ghrelin secretion from the stomach (12,13). Indeed, in support of this formulation a single systemic leptin injection to rAAV-lep-treated leptinopenic and ghrelin hypersecreting wild-type and ob/ob mice rapidly suppressed ghrelin secretion (12,13) (Fig. 4). In support of this in vivo evidence, leptin also suppresses ghrelin release from isolated stomach in vitro (30).
|
Ghrelin and leptin interplay in the ARC-PVN axis for energy homeostasis
The current view holds that gastric ghrelin crosses the blood brain barrier and, in concert with ghrelin produced locally in the hypothalamus, engages the network of NPY and cohorts in the ARC-PVN axis to evoke the appetitive drive (2,31). NPY neurons coexpress ghrelin receptors and the orexigens, agouti-related peptide (AgrP) and
-aminobutyric acid (GABA) (13,8). On the basis of the cumulative evidence that leptinemia after fasting or preceding the onset of a meal is contemporaneous with enhanced pulsatile ghrelin secretion in the periphery as well as NPY synthesis and episodic NPY release in the ARC-PVN axis (7,32) and blockade of ghrelin induced-appetite with NPY Y1 receptor antagonist (14,15), we postulated that appetite stimulation by ghrelin is propagated by dynamic NPY signaling in the ARC-PVN axis (14,8). These effects are apparently supplemented by augmented corelease of AgrP because ghrelin is completely ineffective in NPY and AgrP null mice (33). Seemingly, the premeal ghrelin rise triggers a sequence of events in the ARN. Initiation of synthesis in the ARC is followed by the timely release in the PVN of NPY, AgrP, and GABA, which activate Y1/Y5 and GABAA receptors and block MC4 receptors on NPY target neurons in the magnocellular PVN (mPVN, Fig. 1). These sequalae induce a robust appetitive drive (14,8,3438).
A central effect of leptin is to restrain food intake by suppressing NPY synthesis, release, and action in the ARC-PVN axis (14). This tonic restraint is mediated through activation of the biologically relevant long form of leptin receptors expressed by NPY neurons in the ARC and by NPY targets sites coexpressing Y1/Y5 receptors in the mPVN (3437). Is the dynamic site-specific interplay of leptin and ghrelin in the ARC-PVN axis responsible for episodic appetitive drive? Contrary to expectations, we observed that leptinopenic rAAV-lep-treated rats and mice ate less despite markedly elevated blood ghrelin levels (1113,25,28,29). Because NPY expression in the ARC was drastically suppressed by the locally expressed leptin in these rats and mice (11,2628), this implied that even a robust peripheral ghrelin signal was incapable of countering the leptin restraint on NPYergic signaling. Indeed, this was the case because exogenous ghrelin that readily stimulated feeding in a dose-dependent manner in control mice was ineffective in mice expressing leptin locally in the hypothalamus (12,13) (Fig. 5). Evidently leptin counteracts the ghrelin-induced activation of NPYergic signaling at the level of the NPY ARC-PVN axis (Fig. 1).
|
| CONCLUSIONS |
|---|
|
|
|---|
| FOOTNOTES |
|---|
2 Supported by National Institute of Health DK37273 and NS32727. ![]()
4 Abbreviations used: AgrP, agouti-related peptide; ARC, arcuate nucleus; ARN, appetite-regulating network; GABA,
-aminobutyric acid; lep, leptin; NPY, neuropeptide Y; OR, obesity resistant; PVN, paraventricular nucleus; rAAV, recombinant adeno-associated virus. ![]()
| LITERATURE CITED |
|---|
|
|
|---|
1. Kalra, S. P., Dube, M. G., Pu, S., Xu, B., Horvath, T. L. & Kalra, P. S. (1999) Interacting appetite-regulating pathways in the hypothalamic regulation of body weight. Endocr. Rev. 20:68-100.
2. Kalra, S. P., Bagnasco, M., Otukonyong, E. E., Dube, M. G. & Kalra, P. S. (2003) Rhythmic, reciprocal ghrelin and leptin signaling: new insight in the development of obesity. Regul. Pept. 111:1-11.[Medline]
3. Kalra, S. P. & Kalra, P. S. (2004) NPY: a novel on/off switch for control of appetite and reproduction. Michel, M. C. eds. Neuropeptide Y and Related Peptides 2004:221-249 Springer-Verlag Berlin. .
4. Kalra, S. P. & Kalra, P. S. (2004) Neuropeptide Y: a physiological orexigen modulated by the feedback action of ghrelin and leptin. Endocrine 22:49-56.
5. Bagnasco, M., Kalra, P. S. & Kalra, S. P. (2002) Ghrelin and leptin pulse discharge in fed and fasted rats. Endocrinology 143:726-729.[Abstract]
6. Bagnasco, M., Kalra, P. S. & Kalra, S. P. (2002) Plasma leptin levels are pulsatile in adult rats: effects of gonadectomy. Neuroendocrinology 75:257-263.[Medline]
7. Kalra, S. P., Dube, M. G., Sahu, A., Phelps, C. P. & Kalra, P. S. (1991) Neuropeptide Y secretion increases in the paraventricular nucleus in association with increased appetite for food. Proc. Natl. Acad. Sci. U.S.A. 88:10931-10935.
8. Kalra, S. P. & Kalra, P. S. (2004) NPY and cohorts in regulating appetite, obesity and metabolic syndrome: beneficial effects of gene therapy. Neuropeptides 38:201-211.[Medline]
9. Kalra, P. S. & Kalra, S. P. (2002) Obesity and metabolic syndrome: long-term benefits of central leptin gene therapy. Prous, J. R. eds. Drugs of Today 2002:745-757 Prous Science Barcelona, Spain. .
10. Kalra, S. P. & Kalra, P. S. (2003) Keeping obesity and metabolic syndrome at bay with central leptin and cytokine gene therapy. Hamilton, I. eds. Current Medicinal ChemistryCentral Nervous System Agent 2003:189-199 Bentham Science Publications Ltd. San Francisco, CA. .
11. Dhillon, H., Ge, Y., Minter, R. M., Prima, V., Moldawer, L. L., Muzyczka, N., Zolotukhin, S., Kalra, P. S. & Kalra, S. P. (2000) Long-term differential modulation of genes encoding orexigenic and anorexigenic peptides by leptin delivered by rAAV vector in ob/ob mice. Relationship with body weight change. Regul. Pept. 92:97-105.[Medline]
12. Ueno, N., Dube, M. G., Katz, A., Kalra, P. S. & Kalra, S. P. (2003) Leptin inhibits ghrelin-induced obesity by two distinct central and peripheral mechanisms: effects on adiponectin. 33rd Annual Society for Neuroscience Meeting, Nov. 812, New Orleans, LA 2003.
13. Ueno, N., Dube, M. G., Inui, A., Kalra, P. S. & Kalra, S. P. (2004) Leptin modulates orexigenic effects of ghrelin and attenuates adiponectin and insulin levels and selectively the dark-phase feeding as revealed by central leptin gene therapy. Endocrinology 145:4176-4184.
14. Nakazato, M., Murakami, N., Date, Y., Kojima, M., Matsuo, H., Kangawa, K. & Matsukura, S. (2001) A role for ghrelin in the central regulation of feeding. Nature 409:194-198.[Medline]
15. Tschop, M., Smiley, D. L. & Heiman, M. L. (2000) Ghrelin induces adiposity in rodents. Nature 407:908-913.[Medline]
16. Cowley, M. A., Smith, R. G., Diano, S., Tschop, M., Pronchuk, N., Grove, K. L., Strasburger, C. J., Bidlingmaier, M., Esterman, M., Heiman, M. L., Garcia-Segura, L. M., Nillni, E. A., Mendez, P., Low, M. J., Sotonyi, P., Friedman, J. M., Liu, H., Pinto, S., Colmers, W. F., Cone, R. D. & Horvath, T. L. (2003) The distribution and mechanism of action of ghrelin in the CNS demonstrates a novel hypothalamic circuit regulating energy homeostasis. Neuron 37:649-661.[Medline]
17. Cummings, D. E., Purnell, J. Q., Frayo, R. S., Schmidova, K., Wisse, B. E. & Weigle, D. S. (2001) A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans. Diabetes 50:1714-1719.
18. Tschop, M., Weyer, C., Tataranni, P. A., Devanarayan, V., Ravussin, E. & Heiman, M. L. (2001) Circulating ghrelin levels are decreased in human obesity. Diabetes 50:707-709.
19. Crowley, W. R., Ramoz, G., Keefe, D. A., Torto, R. & Kalra, S. P. (2005) Differential effects of methamphetamine on expression of neuropeptide Y mRNA in hypothalamus and on serum leptin and ghrelin concentrations in ad libitum fed and scheduled fed rats. Neuroscience 132:167-173.[Medline]
20. Ariyasu, H., Takaya, K., Tagami, T., Ogawa, Y., Hosoda, K., Akamizu, T., Suda, M., Koh, T., Natsui, K., Toyooka, S., Shirakami, G., Usui, T., Shimatsu, A., Doi, K., Hosoda, H., Kojima, M., Kangawa, K. & Nakao, K. (2001) Stomach is a major source of circulating ghrelin, and feeding state determines plasma ghrelin-like immunoreactivity levels in humans. J. Clin. Endocrinol. Metab. 86:4753-4758.
21. Asakawa, A., Inui, A., Kaga, T., Katsuura, G., Fujimiya, M., Fujino, M. A. & Kasuga, M. (2003) Antagonism of ghrelin receptor reduces food intake and body weight gain in mice. Gut 52:947-952.
22. Tschop, M., Wawarta, R., Riepl, R. L., Friedrich, S., Bidlingmaier, M., Landgraf, R. & Folwaczny, C. (2001) Post-prandial decrease of circulating human ghrelin levels. J. Endocrinol. Invest. 24:RC19-RC21.[Medline]
23. Xu, B., Kalra, P. S., Farmerie, W. G. & Kalra, S. P. (1999) Daily changes in hypothalamic gene expression of neuropeptide Y, galanin, proopiomelanocortin, and adipocyte leptin gene expression and secretion: effects of food restriction. Endocrinology 140:2868-2875.
24. Otukonyong, E. E., Torto, R., Dube, M. G., Luttge, W. G., Kalra, P. S. & Kalra, S. P. (2003) Altered rhythmicity in peripheral hormonal feedback may encode dietary obesity, p. Su81, abs. 283.10. 33rd Annual Meeting Society for Neuroscience, Nov. 812, New Orleans, LA 2003.
25. Bagnasco, M., Dube, M. G., Katz, A., Kalra, P. S. & Kalra, S. P. (2003) Leptin expression in hypothalamic PVN reverses dietary obesity and hyperinsulinemia but stimulates ghrelin. Obes. Res. 11:1463-1470.[Medline]
26. Dhillon, H., Kalra, S. P. & Kalra, P. S. (2001) Dose-dependent effects of central leptin gene therapy on genes that regulate body weight and appetite in the hypothalamus. Mol. Ther. 4:139-145.[Medline]
27. Beretta, E., Dube, M. G., Kalra, P. S. & Kalra, S. P. (2002) Long-term suppression of weight gain, adiposity, and serum insulin by central leptin gene therapy in prepubertal rats: effects on serum ghrelin and appetite-regulating genes. Pediatr. Res. 52:189-198.[Medline]
28. Bagnasco, M., Dube, M. G., Kalra, P. S. & Kalra, S. P. (2002) Evidence for the existence of distinct central appetite and energy expenditure pathways and stimulation of ghrelin as revealed by hypothalamic site-specific leptin gene therapy. Endocrinology 143:4409-4421.
29. Dube, M. G., Beretta, E., Dhillon, H., Ueno, N., Kalra, P. S. & Kalra, S. P. (2002) Central leptin gene therapy blocks high fat diet-induced weight gain, hyperleptinemia and hyperinsulinemia: effects on serum ghrelin levels. Diabetes 51:1729-1736.
30. Kamegai, J., Tamura, H., Shimizu, T., Ishii, S., Sugihara, H. & Oikawa, S. (2004) Effects of insulin, leptin, and glucagon on ghrelin secretion from isolated perfused rat stomach. Regul. Pept. 119:77-81.[Medline]
31. Horvath, T. L., Diano, S., Sotonyi, P., Heiman, M. & Tschop, M. (2001) Minireview: ghrelin and the regulation of energy balancea hypothalamic perspective. Endocrinology 142:4163-4169.
32. Sahu, A., White, J. D., Kalra, P. S. & Kalra, S. P. (1992) Hypothalamic neuropeptide Y gene expression in rats on scheduled feeding regimen. Brain Res. Mol. Brain Res. 15:15-18.[Medline]
33. Chen, H. Y., Trumbauer, M. E., Chen, A. S., Weingarth, D. T., Adams, J. R., Frazier, E. G., Shen, Z., Marsh, D. J., Feighner, S. D., Guan, X. M., Ye, Z., Nargund, R. P., Smith, R. G., Van Der Ploeg, L. H., Howard, A. D., MacNeil, D. J. & Qian, S. (2004) Orexigenic action of peripheral ghrelin is mediated by neuropeptide Y (NPY) and agouti-related protein (AgRP). Endocrinology 145:2607-2612.
34. Bagnasco, M., Tulipano, G., Melis, M. R., Argiolas, A., Cocchi, D. & Muller, E. E. (2003) Endogenous ghrelin is an orexigenic peptide acting in the arcuate nucleus in response to fasting. Regul. Pept. 111:161-167.[Medline]
35. Yokosuka, M., Xu, B., Pu, S., Kalra, P. S. & Kalra, S. P. (1998) Neural substrates for leptin and neuropeptide Y (NPY) interaction: hypothalamic sites associated with inhibition of NPY-induced food intake. Physiol. Behav. 64:331-338.[Medline]
36. Yokosuka, M., Kalra, P. S. & Kalra, S. P. (1999) Inhibition of neuropeptide Y (NPY)-induced feeding and c-Fos response in magnocellular paraventricular nucleus by a NPY receptor antagonist: a site of NPY action. Endocrinology 140:4494-4500.
37. Yokosuka, M., Dube, M. G., Kalra, P. S. & Kalra, S. P. (2001) The mPVN mediates blockade of NPY-induced feeding by a Y5 receptor antagonist: a c-FOS analysis. Peptides 22:507-514.[Medline]
38. Traebert, M., Riediger, T., Whitebread, S., Scharrer, E. & Schmid, H. A. (2002) Ghrelin acts on leptin-responsive neurones in the rat arcuate nucleus. J. Neuroendocrinol. 14:580-586.[Medline]
39. Pu, S., Dube, M. G., Kalra, P. S. & Kalra, S. P. (2000) Regulation of leptin secretion: Effects of aging on daily patterns of serum leptin and food consumption. Regul. Pept. 92:107-111.[Medline]
This article has been cited by other articles:
![]() |
M.-M. Theil, S. Miyake, M. Mizuno, C. Tomi, J. L. Croxford, H. Hosoda, J. Theil, S. von Horsten, H. Yokote, A. Chiba, et al. Suppression of Experimental Autoimmune Encephalomyelitis by Ghrelin J. Immunol., August 15, 2009; 183(4): 2859 - 2866. [Abstract] [Full Text] [PDF] |
||||
![]() |
C Letelier, F Mallo, T Encinas, J M Ros, and A Gonzalez-Bulnes Glucogenic supply increases ovulation rate by modifying follicle recruitment and subsequent development of preovulatory follicles without effects on ghrelin secretion Reproduction, July 1, 2008; 136(1): 65 - 72. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. E. Truett and E. J. Parks Ghrelin: Its Role in Energy Balance J. Nutr., May 1, 2005; 135(5): 1313 - 1313. [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||